FDA clears tiratricol for MCT8 deficiency, lowering dangerous T3 and outlining dosing, lab testing, and pharmacy access.
|Videos|May 12, 2017
How eAccess Technology Can Benefit Specialty Pharmacy
Author(s)Lauren Santye, Assistant Editor
Gregory R. Morris, chief commercial officer at VirMedica, discusses the eAccess program for specialty pharmacies.
Advertisement
Gregory R. Morris, chief commercial officer at VirMedica, discusses the eAccess program for specialty pharmacies.
Advertisement
Related to this article
AI-driven coding fuels specialty EHRs and telehealth tools, making ePrescribing faster, tailored, and affordable while shifting focus to workflow and compliance.
The once-daily tablet is the third approved treatment for fibrodysplasia ossificans progressiva (FOP), with CYP3A4 and metformin interaction guidance.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tirzepatide Linked to More Weight Loss Than Semaglutide 7.2 mg
2
September 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
3
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
4
Orforglipron Edges Oral Semaglutide 25 mg in T2D, Indirect Comparison Finds
5